Demonstration of the Protective Effect of Vinpocetine in Diabetic Cardiomyopathy.

J Clin Med · 2024 · PMC11354616 · PMID 39200779

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Treatment with Vinpocetine in the Diabetes and Vinpocetine group showed a trend towards normalization of neuregulin-1β levels, although not reaching significance compared to the Diabetes and saline treatment group. 3.4.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.